The Journal of Heart and Lung Transplantation
Volume 25, Issue 9 , Pages 1043-1056 , September 2006

Heart Rhythm Considerations in Heart Transplant Candidates and Considerations for Ventricular Assist Devices: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006

Received 27 May 2006 ,Revised 27 May 2006 ,Accepted 16 June 2006.

References 

  1. Grines CL , Bashore TM , Boudoulas H , Olson S , Shafer P , Wooley CF . Functional abnormalities in isolated left bundle branch block (The effect of interventricular asynchrony) . Circulation . 1989;79:845–853
  2. Nesser HJ , Breithardt OA , Khandheria BK . Established and evolving indications for cardiac resynchronisation . Heart . 2004;90(suppl 6):vi5–vi9
  3. Abraham WT , Hayes DL . Cardiac resynchronization therapy for heart failure . Circulation . 2003;108:2596–2603
  4. Kalahasti V , Nambi V , Martin DO , et al.   QRS duration and prediction of mortality in patients undergoing risk stratification for ventricular arrhythmias . Am J Cardiol . 2003;92:798–803
  5. Mann DL . Mechanisms and models in heart failure: a combinatorial approach . Circulation . 1999;100:999–1008
  6. Oikarinen L , Nieminen MS , Viitasalo M , et al.   QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension Study . Hypertension . 2004;43:1029–1034
  7. McAlister FA , Ezekowitz JA , Wiebe N , et al.   Systematic review: cardiac resynchronization in patients with symptomatic heart failure . Ann Intern Med . 2004;141:381–390
  8. Cleland JG , Ghosh J , Khan NK , Ghio S , Tavazzi L , Kaye G . Multi-chamber pacing: a perfect solution for cardiac mechanical dyssynchrony? . Eur Heart J . 2003;24:384–390
  9. Luck JC , Wolbrette DL , Boehmer JP , Ulsh PJ , Silber D , Naccarelli GV . Biventricular pacing in congestive heart failure: a boost toward finer living . Curr Opin Cardiol . 2002;17:96–101
  10. Abraham WT , Fisher WG , Smith AL , et al.   Cardiac resynchronization in chronic heart failure . N Engl J Med . 2002;346:1845–1853
  11. Packer M . Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure . J Card Fail . 2001;7:176–182
  12. Kay GN , Bourge RC . Biventricular pacing for congestive heart failure: questions of who, what, where, why, how, and how much . Am Heart J . 2000;140:821–823
  13. Bristow MR , Saxon LA , Boehmer J , et al.   Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure . N Engl J Med . 2004;350:2140–2150
  14. Cleland JG , Daubert JC , Erdmann E , et al.   The effect of cardiac resynchronization on morbidity and mortality in heart failure . N Engl J Med . 2005;352:1539–1549
  15. Curtis AB . Cardiac resynchronization therapy 101: if it’s not late, pacing it early won’t help . J Am Coll Cardiol . 2005;45:70–71
  16. Bax JJ , Ansalone G , Breithardt OA , et al.   Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? (A critical appraisal) . J Am Coll Cardiol . 2004;44:1–9
  17. Fauchier L , Marie O , Casset-Senon D , Babuty D , Cosnay P , Fauchier JP . Interventricular and intraventricular dyssynchrony in idiopathic dilated cardiomyopathy: a prognostic study with Fourier phase analysis of radionuclide angioscintigraphy . J Am Coll Cardiol . 2002;40:2022–2030
  18. Luu M , Stevenson WG , Stevenson LW , Baron K , Walden J . Diverse mechanisms of unexpected cardiac arrest in advanced heart failure . Circulation . 1989;80:1675–1680
  19. Buxton AE , Lee KL , DiCarlo L , et al.  Multicenter Unsustained Tachycardia Trial Investigators   Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death . N Engl J Med . 2000;342:1937–1945
  20. Knight BP , Goyal R , Pelosi F , et al.   Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator . J Am Coll Cardiol . 1999;33:1964–1970
  21. Moss AJ , Zareba W , Hall WJ , et al.   Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction . N Engl J Med . 2002;346:877–883
  22. Bardy GH , Lee KL , Mark DB , et al.   Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure . N Engl J Med . 2005;352:225–237
  23. Kadish A , Dyer A , Daubert JP , et al.   Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy . N Engl J Med . 2004;350:2151–2158
  24. Lang CC , Hankins S , Hauff H , Maybaum S , Edwards N , Mancini DM . Morbidity and mortality of UNOS Status 1B cardiac transplant candidates at home . J Heart Lung Transplant . 2003;22:419–426
  25. Brozena SC , Twomey C , Goldberg LR , et al.   A prospective study of continuous intravenous milrinone therapy for Status IB patients awaiting heart transplant at home . J Heart Lung Transplant . 2004;23:1082–1086
  26. Massie BM , Fisher SG , Radford M , et al.  CHF-STAT Investigators   Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure . Circulation . 1996;93:2128–2134
  27. Sim I , McDonald KM , Lavori PW , Norbutas CM , Hlatky MA . Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death . Circulation . 1997;96:2823–2829
  28. Feldman AM , Klein H , Tchou P , et al.   Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD . Pacing Clin Electrophysiol . 2004;27:4–9
  29. Frazier OH , Delgado RM . Mechanical circulatory support for advanced heart failure: where does it stand in 2003? . Circulation . 2003;108:3064–3068
  30. Felker GM , Rogers JG . Same bridge, new destinations rethinking paradigms for mechanical cardiac support in heart failure . J Am Coll Cardiol . 2006;47:930–932
  31. Deng MC , Edwards LB , Hertz MI , et al.   Mechanical Circulatory Support Device Database of the International Society for Heart and Lung Transplantation: second annual report—2004 . J Heart Lung Transplant . 2004;23:1027–1034
  32. Aaronson KD , Patel H , Pagani FD . Patient selection for left ventricular assist device therapy . Ann Thorac Surg . 2003;75(suppl):S29–S35
  33. Miller LW . Patient selection for the use of ventricular assist devices as a bridge to transplantation . Ann Thorac Surg . 2003;75(suppl):S66–S71
  34. Williams MR , Oz MC . Indications and patient selection for mechanical ventricular assistance . Ann Thorac Surg . 2001;71(suppl):S86–S91
  35. Deng MC , Loebe M , El-Banayosy A , et al.   Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome . Circulation . 2001;103:231–237
  36. Jurmann MJ , Weng Y , Drews T , Pasic M , Hennig E , Hetzer R . Permanent mechanical circulatory support in patients of advanced age . Eur J Cardiothorac Surg . 2004;25:610–618
  37. Dembitsky WP , Tector AJ , Park S , et al.   Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial . Ann Thorac Surg . 2004;78:2123–2129
  38. Granfeldt H , Koul B , Wiklund L , et al.   Risk factor analysis of Swedish left ventricular assist device (LVAD) patients . Ann Thorac Surg . 2003;76:1993–1998
  39. McBride LR , Naunheim KS , Fiore AC , et al.   Risk analysis in patients bridged to transplantation . Ann Thorac Surg . 2001;71:1839–1844
  40. Rao V , Oz MC , Flannery MA , Catanese KA , Argenziano M , Naka Y . Revised screening scale to predict survival after insertion of a left ventricular assist device . J Thorac Cardiovasc Surg . 2003;125:855–862
  41. Brandt M , Koch MT , Steinhoff G , et al.   Do long-term results justify bridging to heart transplantation in patients with multi-organ dysfunction? . Thorac Cardiovasc Surg . 1996;44:277–281
  42. Novis BK , Roizen MF , Aronson S , Thisted RA . Association of preoperative risk factors with postoperative acute renal failure . Anesth Analg . 1994;78:143–149
  43. Aronson S , Blumenthal R . Perioperative renal dysfunction and cardiovascular anesthesia: concerns and controversies . J Cardiothorac Vasc Anesthesiol . 1998;12:567–586
  44. Parker RA , Himmelfarb J , Tolkoff-Rubin N , Chandran P , Wingard RL , Hakim RM . Prognosis of patients with acute renal failure requiring dialysis: results of a multicenter study . Am J Kidney Dis . 1998;32:432–443
  45. Christensen E . Prognostic models including the Child–Pugh, MELD and Mayo risk scores—where are we and where should we go? . J Hepatol . 2004;41:344–350
  46. Suman A , Barnes DS , Zein NN , Levinthal GN , Connor JT , Carey WD . Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child–Pugh and MELD scores . Clin Gastroenterol Hepatol . 2004;2:719–723
  47. Masai T , Sawa Y , Ohtake S , et al.   Hepatic dysfunction after left ventricular mechanical assist in patients with end-stage heart failure: role of inflammatory response and hepatic microcirculation . Ann Thorac Surg . 2002;73:549–555
  48. Reinhartz O , Farrar DJ , Hershon JH , et al.   Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist devices as a bridge to transplantation . J Thorac Cardiovasc Surg . 1998;116:633–640
  49. Liaw PC , Esmon CT , Kahnamoui K , et al.   Patients with severe sepsis vary markedly in their ability to generate activated protein C . Blood . 2004;104:3958–3964
  50. Cohen J . The immunopathogenesis of sepsis . Nature . 2002;420:885–891
  51. Hotchkiss RS , Karl IE . The pathophysiology and treatment of sepsis . N Engl J Med . 2003;348:138–150
  52. Le TY , Pangault C , Gacouin A , et al.   Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome . Shock . 2002;18:487–494
  53. Maury E , Blanchard HS , Chauvin P , et al.   Circulating endotoxin and antiendotoxin antibodies during severe sepsis and septic shock . J Crit Care . 2003;18:115–120
  54. Strutz F , Heller G , Krasemann K , Krone B , Muller GA . Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome . Intensive Care Med . 1999;25:435–444
  55. Barbone A , Pini D , Grossi P , et al.   Aspergillus left ventricular assist device endocarditis . Ital Heart J . 2004;5:876–880
  56. Nurozler F , Argenziano M , Oz MC , Naka Y . Fungal left ventricular assist device endocarditis . Ann Thorac Surg . 2001;71:614–618
  57. Swartz MT , Lowdermilk GA , McBride LR . Refractory ventricular tachycardia as an indication for ventricular assist device support . J Thorac Cardiovasc Surg . 1999;118:1119–1120
  58. Oz MC , Rose EA , Slater J , Kuiper JJ , Catanese KA , Levin HR . Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices . J Am Coll Cardiol . 1994;24:1688–1691
  59. Kucuker SA , Stetson SJ , Becker KA , et al.   Evidence of improved right ventricular structure after LVAD support in patients with end-stage cardiomyopathy . J Heart Lung Transplant . 2004;23:28–35
  60. Morgan JA , John R , Lee BJ , Oz MC , Naka Y . Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and posttransplant mortality? . Ann Thorac Surg . 2004;77:859–863
  61. Ochiai Y , McCarthy PM , Smedira NG , et al.   Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients . Circulation . 2002;106(suppl 1):I-198–I-202
  62. Holman WL , Bourge RC , Fan P , Kirklin JK , Pacifico AD , Nanda NC . Influence of longer term left ventricular assist device support on valvular regurgitation . ASAIO J . 1994;40:M454–M459
  63. Barbone A , Rao V , Oz MC , Naka Y . LVAD support in patients with bioprosthetic valves . Ann Thorac Surg . 2002;74:232–234
  64. Park SJ , Liao KK , Segurola R , Madhu KP , Miller LW . Management of aortic insufficiency in patients with left ventricular assist devices: a simple coaptation stitch method (Park’s stitch) . J Thorac Cardiovasc Surg . 2004;127:264–266
  65. Rao V , Slater JP , Edwards NM , Naka Y , Oz MC . Surgical management of valvular disease in patients requiring left ventricular assist device support . Ann Thorac Surg . 2001;71:1448–1453
  66. Tisol WB , Mueller DK , Hoy FB , Gomez RC , Clemson BS , Hussain SM . Ventricular assist device use with mechanical heart valves: an outcome series and literature review . Ann Thorac Surg . 2001;72:2051–2054
  67. Butler J , Howser R , Portner PM , Pierson RN . Body mass index and outcomes after left ventricular assist device placement . Ann Thorac Surg . 2005;79:66–73
  68. Sichieri R , Everhart JE , Hubbard VS . Relative weight classifications in the assessment of underweight and overweight in the United States . Int J Obes Relat Metab Disord . 1992;16:303–312
  69. Anker SD , Ponikowski P , Varney S , et al.   Wasting as independent risk factor for mortality in chronic heart failure . Lancet . 1997;349:1050–1053
  70. Stevenson LW , Kormos RL , Barr ML , et al.   Mechanical cardiac support 2000: current applications and future trial design, June 15–16, 2000, Bethesda, Maryland . Circulation . 2001;103:337–342
  71. Levenson JL , Olbrisch ME . Psychosocial evaluation of organ transplant candidates (A comparative survey of process, criteria, and outcomes in heart, liver, and kidney transplantation) . Psychosomatics . 1993;34:314–323
  72. Dew MA , Kormos RL , Winowich S , et al.   Human factors issues in ventricular assist device recipients and their family caregivers . ASAIO J . 2000;46:367–373
  73. Dew MA , Kormos RL , Winowich S , et al.   Quality of life outcomes after heart transplantation in individuals bridged to transplant with ventricular assist devices . J Heart Lung Transplant . 2001;20:1199–1212
  74. Grady KL , Meyer P , Mattea A , et al.   Predictors of quality of life at 1 month after implantation of a left ventricular assist device . Am J Crit Care . 2002;11:345–352
  75. Grady KL , Meyer PM , Mattea A , et al.   Change in quality of life from before to after discharge following left ventricular assist device implantation . J Heart Lung Transplant . 2003;22:322–333
  76. Savage L . Quality of life among patients with a left ventricular assist device: what is new? . AACN Clin Issues . 2003;14:64–72
  77. Cuffe MS , Califf RM , Adams KF , et al.   Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial . JAMA . 2002;287:1541–1547
  78. Gallagher RC , Kormos RL , Gasior T , Murali S , Griffith BP , Hardesty RL . Univentricular support results in reduction of pulmonary resistance and improved right ventricular function . ASAIO Trans . 1991;37:M287–M288
  79. Stevenson LW , Miller LW , Svigne-Nickens P , et al.   Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure) . Circulation . 2004;110:975–981
  80. Mustafa I , Leverve X . Metabolic and nutritional disorders in cardiac cachexia . Nutrition . 2001;17:756–760
  81. Baudouin SV , Evans TW . Nutritional support in critical care . Clin Chest Med . 2003;24:633–644
  82. Sabol VK . Nutrition assessment of the critically ill adult . AACN Clin Issues . 2004;15:595–606
  83. Thoratec Corporation . Nutrition management in advanced practice guidelines for HeartMate destination therapy . Pleasanton, CA: Thoratec Corporation; 2004; Report no. 1.
  84. DiNardo MM , Korytkowski MT , Siminerio LS . The importance of normoglycemia in critically ill patients . Crit Care Nurs Q . 2004;27:126–134
  85. van den Berghe G , Wouters P , Weekers F , et al.   Intensive insulin therapy in the critically ill patients . N Engl J Med . 2001;345:1359–1367
  86. Andrus S , Dubois J , Jansen C , Kuttner V , Lansberry N , Lukowski L . Teaching documentation tool: building a successful discharge . Crit Care Nurse . 2003;23:39–48
  87. Richenbacher WE , Seemuth SC . Hospital discharge for the ventricular assist device patient: historical perspective and description of a successful program . ASAIO J . 2001;47:590–595
  88. Casida J . The lived experience of spouses of patients with a left ventricular assist device before heart transplantation . Am J Crit Care . 2005;14:145–151
  89. Golper TA , Glasco GB . Dialysis and hemofiltration for congestive heart failure . Philadelphia: Lippincott, Williams, & Wilkins; 2000;
  90. Mehrotra R , Khanna R . Peritoneal ultrafiltration for chronic congestive heart failure: rationale, evidence and future . Cardiology . 2001;96:177–182
  91. van Krediet RT , Zweers MM , Struijk DG . Clinical advantages of new peritoneal dialysis solutions . Nephrol Dial Transplant . 2002;17(suppl 3):16–18
  92. Jaski BE , Ha J , Denys BG , Lamba S , Trupp RJ , Abraham WT . Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients . J Card Fail . 2003;9:227–231
  93. Costanzo MR , Saltzberg MT , O’Sullivan J , Sobotka P . Early ultrafiltration in patients with decompensated heart failure and diuretic resistance . J Am Coll Cardiol . 2005;46:2043–2051
  94. Saltzberg MT , Costanzo MR , O’Neill MC , et al.   Mechanical diuresis: a novel treatment for patients with decompensated heart failure J Card Fail . 2003;9:S46
  95. Agostoni P , Marenzi G , Lauri G , et al.   Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result . Am J Med . 1994;96:191–199
  96. Agostoni PG , Marenzi GC , Pepi M , et al.   Isolated ultrafiltration in moderate congestive heart failure . J Am Coll Cardiol . 1993;21:424–431
  97. Agostoni PG , Marenzi GC , Sganzerla P , et al.   Lung–heart interaction as a substrate for the improvement in exercise capacity after body fluid volume depletion in moderate congestive heart failure . Am J Cardiol . 1995;76:793–798
  98. Bart BA , Boyle A , Bank AJ , et al.   Ultrafiltration versus usual care for hospitalized patients with decompensated congestive heart failure (RAPID-CHF) trial . J Am Coll Cardiol . 2005;46:2043–2046
  99. Bellomo R , Raman J , Ronco C . Intensive care unit management of the critically ill patient with fluid overload after open heart surgery . Cardiology . 2001;96:169–176
  100. Guazzi MD , Agostoni P , Perego B , et al.   Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention . Br Heart J . 1994;72:534–539
  101. Marenzi G , Lauri G , Grazi M , Assanelli E , Campodonico J , Agostoni P . Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure . J Am Coll Cardiol . 2001;38:963–968
  102. Marenzi GC , Lauri G , Guazzi M , Perego GB , Agostoni PG . Ultrafiltration in moderate heart failure (Exercise oxygen uptake as a predictor of the clinical benefits) . Chest . 1995;108:94–98
  103. Pepi M , Marenzi GC , Agostoni PG , et al.   Sustained cardiac diastolic changes elicited by ultrafiltration in patients with moderate congestive heart failure: pathophysiological correlates . Br Heart J . 1993;70:135–140
  104. Rimondini A , Cipolla CM , Della BP , et al.   Hemofiltration as short-term treatment for refractory congestive heart failure . Am J Med . 1987;83:43–48
  105. Ronco C , Ricci Z , Bellomo R , Bedogni F . Extracorporeal ultrafiltration for the treatment of overhydration and congestive heart failure . Cardiology . 2001;96:155–168

 Reprint requests: Amanda Rowe, Executive Director, ISHLT, 14673 Midway Road, Suite 200, Addison, TX 75001. E-mail: amanda.rowe@ishlt.org

PII: S1053-2498(06)00457-8

doi: 10.1016/j.healun.2006.06.005

The Journal of Heart and Lung Transplantation
Volume 25, Issue 9 , Pages 1043-1056 , September 2006

Article Tools